- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: AstraZeneca vaccine covid.
Displaying page 1 of 1.
| EudraCT Number: 2021-004788-29 | Sponsor Protocol Number: Covid_vacc_THL2021 | Start Date*: 2021-12-23 | |||||||||||
| Sponsor Name:Finnish Institute for Health and Welfare | |||||||||||||
| Full Title: COVID-19 vaccine immunological studies in Finland | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-002171-19 | Sponsor Protocol Number: HEVACC | Start Date*: 2021-05-12 | |||||||||||
| Sponsor Name:Medizinische Universität Innsbruck, Institut für Virologie | |||||||||||||
| Full Title: Heterologous vaccination with a Vaxzervia (ChAdOx1-S) prime and a Comirnaty (BNT162b2) boost | |||||||||||||
| Medical condition: Immunization for SARS-CoV-2 | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000988-68 | Sponsor Protocol Number: O2021-1 | Start Date*: 2021-03-31 |
| Sponsor Name: Region Stockholm | ||
| Full Title: Immune response after covid-19 vaccination in patients with renal failure stadium 4 or 5 . | ||
| Medical condition: Renal failure stage 4 and 5. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-000440-22 | Sponsor Protocol Number: Version17032021 | Start Date*: 2021-03-25 |
| Sponsor Name:Universiteit Antwerpen | ||
| Full Title: Vaccination against COVID-19 in Pregnant and Lactating Women in Belgium | ||
| Medical condition: Vaccine responses to COVID19 vaccines administered in pregnant and lactating women | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-004419-14 | Sponsor Protocol Number: T125/2020 | Start Date*: 2021-10-18 |
| Sponsor Name:Turku University Hospital | ||
| Full Title: COVID-19 infections in hospital personnel | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000710-42 | Sponsor Protocol Number: RR-xx-RTX-COVAC | Start Date*: 2021-03-15 | |||||||||||
| Sponsor Name:Sint Maartenskliniek | |||||||||||||
| Full Title: The RTX-COVAC study: humoral response to COVID-19 vaccination after rituximab, and relation with dose and vaccination timing. A prospective cohort study. | |||||||||||||
| Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-002348-57 | Sponsor Protocol Number: 2021-002348-57 | Start Date*: 2021-05-30 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: A Randomized, Parallel Group, Single-Blind, Phase 2 Study to Evaluate the immune response of two classes of SARS-Cov-2 Vaccines employed as Third Vaccination in Patients under current Rituximab The... | ||
| Medical condition: Vaccination against SARS-CoV-2 in patients with rituximab therapy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001391-42 | Sponsor Protocol Number: Speed-Covid | Start Date*: 2021-05-12 |
| Sponsor Name:Medical University of Graz | ||
| Full Title: Characterisation of the effects of Spermidine on the immune response to Covid-19 vaccine in older people - a feasibility study | ||
| Medical condition: For assessing the immune cell function after COVID-19 vaccine, peripheral blood mononuclear cells (PBMC) will be separated after blood sampling and measurements as follows will be done: • FACS anal... | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001512-28 | Sponsor Protocol Number: COVIM | Start Date*: 2021-05-11 | |||||||||||
| Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
| Full Title: Immunogenicity of COVID-19 vaccines in medical staff and special risk populations | |||||||||||||
| Medical condition: SARS-CoV-2 immunogenicity | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
